{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210415",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1/4",
          "submission_class_code_description": "Type 1 - New Molecular Entity and Type 4 - New Combination",
          "application_docs": [
            {
              "id": "67062",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214154s000lbl.pdf",
              "date": "20210415",
              "type": "Label"
            },
            {
              "id": "67081",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214154Orig1s000ltr.pdf",
              "date": "20210416",
              "type": "Letter"
            },
            {
              "id": "67459",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/214154Orig1s000TOC.html",
              "date": "20210512",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20220429",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "70906",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214154s002lbl.pdf",
              "date": "20220502",
              "type": "Label"
            },
            {
              "id": "70956",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214154Orig1s002ltr.pdf",
              "date": "20220503",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA214154",
      "sponsor_name": "MAYNE PHARMA",
      "openfda": {
        "application_number": [
          "NDA214154"
        ],
        "brand_name": [
          "NEXTSTELLIS"
        ],
        "generic_name": [
          "DROSPIRENONE AND ESTETROL"
        ],
        "manufacturer_name": [
          "Mayne Pharma"
        ],
        "product_ndc": [
          "51862-258"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "rxcui": [
          "748797",
          "2539032",
          "2539033",
          "2539036"
        ],
        "spl_id": [
          "cb3d0738-1ec9-47a9-9167-8a4eb905ddab"
        ],
        "spl_set_id": [
          "c5270073-d083-4109-ae4b-156986175e0a"
        ],
        "package_ndc": [
          "51862-258-01",
          "51862-258-00",
          "51862-259-24",
          "51862-261-04"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "NEXTSTELLIS",
          "active_ingredients": [
            {
              "name": "DROSPIRENONE",
              "strength": "3MG"
            },
            {
              "name": "ESTETROL",
              "strength": "14.2MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}